You were given 109 shares of MPLX. It was my understanding that this was not a fully taxable event. I am confident of that. I am thinking that for many, the cash will be considered return of capital. I am less confident of that. It would be nice if there was an investor relations document that spelled that out. Anyway, the K01 will tell the story though it is not easy figuring out where the numbers came from.
AstraZeneca, a UK company, is buying ZSPH in a tender offer expected to close this year. The price action tells you it will happen for real. ZSPH holders will pay CG tax for 2015. This is probably motivated by tax efficiencies of moving away from US taxes.
It seems shocking that this is not easy to find (I could not) on either company's website. You would think that one of them would have made it obvious -- maybe I am too oblivious.
AZN, a UK company, is buying ZSPH. Deal is expended to close this year, and ZSPH stockholders pay the capital gains tax on their 2015 taxes. By moving headquarters to the UK, there will be less tax on these operations. It's a little like a tax inversion, but it is a cash buyout.
There is a tender which I have not looked into. I suspect it gets cash to the holders a little sooner, but you have to be careful that the tender is for the full $90. Sometimes tenders are made by third parties trying to bet a bargain. I doubt that is what this is, but pay attention.